We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Nanoprinter to Mass-Produce NanoDevices

By Biotechdaily staff writers
Posted on 28 Jun 2005
A new "nano-printing” technique could enable the mass-production of nano-devices manufactured one at a time.

Clearly the most immediate candidate for this technology is the DNA microarray, nano-devices utilized to identify and evaluate genetic disorders including viral illnesses such as AIDs, Alzheimer's disease, and certain kinds of cancer. More...
The capability to generate these complicated devices would make DNA analysis as ordinary and economical as blood testing, thereby significantly speeding up efforts to understand the mechanisms of disease.

The demand for smaller devices of increasing complexity in areas from biomedicine to information technology has prompted several research efforts toward high-resolution, high-throughput nano-printing techniques. Researchers led by Prof. Francesco Stellacci, from the department of materials science and engineering at the Massachusetts Institute of Technology (MIT, Boston, MA, USA) have developed a printing method that is unrivaled in both information content per printing cycle and resolution. They achieved the latter using what Arum Amy Yu, an MIT graduate student and member of the research team, calls "nature's most efficient printing technique: the DNA/RNA information transfer.”

In the new printing technique, called supramolecular nano-stamping (SuNS), single strands of DNA basically self-assemble upon a surface to copy a nano-scale pattern made of their complementary DNA strands. The duplicates are identical to the master and can therefore be used as masters themselves. This increases print output exponentially while enabling the reproduction of very complicated nano-scale patterns.

One of these patterns is found on a DNA microarray, a glass chip or silicon printed with up to 500,000 tiny dots. Each dot is made up of multiple DNA molecules of known sequence, i.e., a snippet of an individual's genetic code. Researchers use DNA microarrays to find and analyze a person's DNA or messenger-RNA genetic code. Frequent, widespread use of these devices is complicated by the fact that producing them is a painstaking process that involves at least 400 printing steps and costs about U.S.$500 per microarray.

MIT's nano-printing technique requires only three steps and could reduce the cost of each microarray to under U.S.$50. "This would completely revolutionize diagnostics,” said Prof. Stellacci. With the ability to mass-produce these devices and thereby make DNA analysis routine, "we could know years in advance of cancer, hepatitis, or Alzheimer's.”

Another advantage would be large-scale diagnostics that could provide beneficial data about disease processes such as diabetes. "We don't know if it's genetic. The only way to find out is to test a lot of people,” said Prof. Stellacci. "The more we test with microarrays, the more we know about illnesses, and the more we can detect them.”

SuNS has applications beyond DNA microarrays. Materials both organic and inorganic (i.e., metal nanoparticles) can be made to assemble along a pattern comprised of DNA strands. This makes SuNS a versatile method that could be used to produce other complex nano-devices currently manufactured slowly and expensively: micro- and nano-fluidics channels, single-electron transistors, metallic wires, and optical biosensors.

A report on the technology was published in May 2005 in the online section of the journal Nano Letters.




Related Links:
Massachusetts Institute of Technology >

New
Gold Member
Automatic Hematology Analyzer
CF9600
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Clinical Informatics Platform
CLARION™
New
HIV-1 Molecular Diagnostic Assay
AltoStar HIV RT-PCR Kit 1.5
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.